Jan 21, 2026 07:07AM
Jan 7, 2026 07:00AM
Dec 26, 2025 08:30AM
Dec 26, 2025 08:30AM
Nov 5, 2025 04:01PM
Oct 16, 2025 07:00AM
Oct 16, 2025 07:00AM Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
Oct 7, 2025 12:45PM
Oct 7, 2025 06:45AM
Oct 7, 2025 06:45AM
Aug 7, 2025 04:01PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 23, 2025 07:46AM H.C. Wainwright Assumes Adicet Bio Inc. (ACET) at Buy
May 6, 2025 04:01PM
Apr 17, 2025 07:01AM
Apr 17, 2025 07:00AM
Mar 7, 2025 06:47AM
Mar 6, 2025 04:01PM
Feb 27, 2025 07:02AM
Feb 27, 2025 07:00AM Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)
Feb 5, 2025 07:10AM
Feb 5, 2025 07:10AM
Jan 8, 2025 04:10PM
Jan 8, 2025 04:10PM
Dec 19, 2024 07:03AM
Dec 19, 2024 07:00AM
Dec 18, 2024 07:00AM Adicet Bio (ACET) Appoints Julie Maltzman as Chief Medical Officer
Dec 18, 2024 07:00AM
Nov 18, 2024 04:00PM
Nov 18, 2024 04:00PM
Nov 18, 2024 07:09AM
Nov 18, 2024 07:00AM
Nov 16, 2024 09:00AM
Nov 7, 2024 06:14AM Guggenheim Reiterates Buy Rating on Adicet Bio Inc. (ACET)
Nov 6, 2024 04:00PM
Oct 17, 2024 06:56AM
Oct 16, 2024 07:01AM
Oct 16, 2024 07:00AM
Oct 1, 2024 07:04AM
Sep 30, 2024 07:00AM
Sep 20, 2024 06:51AM H.C. Wainwright Reiterates Neutral Rating on Adicet Bio Inc. (ACET)
Sep 19, 2024 07:02AM
Sep 19, 2024 07:00AM
Aug 19, 2024 07:01AM
Aug 19, 2024 07:00AM
Aug 13, 2024 07:00AM
Jul 8, 2024 07:02AM
Jul 8, 2024 07:00AM Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
Jun 24, 2024 07:03AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All